Downregulation of the Endothelin System of Lung Myofibroblasts in Congestive Heart Failure

被引:1
|
作者
Prefontaine, Annick [1 ]
Calderone, Angelino [1 ,2 ]
Dupuis, Jocelyn [1 ,3 ]
机构
[1] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada
[2] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada
[3] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada
基金
加拿大健康研究院;
关键词
remodelling; cardiomyopathy; vasoactive peptides; receptors; cell culture; myofibroblasts; endothelin; PULMONARY-HYPERTENSION; MYOCARDIAL-INFARCTION; PLASMA ENDOTHELIN-1; FIBROBLASTS; PROLIFERATION; CONDUCTANCE; SECRETION; CELLS;
D O I
10.1097/FJC.0b013e3181ad7d57
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congestive heart failure (CHF) causes lung remodelling with thickening of the alveolar septa and proliferation of myofibroblasts (MYF). Endothelin-1 (ET-1) is increased in CHF and may contribute to this process. CHF was induced in rats by myocardial infarction. After three weeks there was lung remodelling with thickening of alveolar septa and increases in 5'-bromodeoxyuridine uptake and vimentin expression (P < 0.05). The mitogenic and protein synthesis response of MYF to ET-1 (10 nM) were assessed by 3 H-thymidine and H-3-leucine incorporation respectively. The mitogenie response in CHF (19.0 +/- 3.0%, mean SEM) was less than for sham rats (35 +/- 5.4%, P < 0.05). This was associated with a lower production of ET-1 by CHF MYF (15.15 +/- 5.67 fmol/ml) compared to sham (33.66 +/- 13.22 fmol/ml; P < 0.05). Additionally, protein expression of ETA (0.36 +/- 0.038 AU) and ETB receptors (0.24 +/- 0.075 AU) were reduced in CHF compared to shams (0.65 +/- 0.086 AU and 0.81 +/- 0.21 AU respectively; P < 0.05). There is a downregulation of the ET system of lung MYF in CHF with reduced proliferation in response to ET-1. This may represent a protective adaptation to counteract lung remodelling in response to chronic exposure to high levels of ET-1.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [1] Bosentan and the endothelin system in congestive heart failure
    Ellahham, SH
    Charlon, V
    Abassi, Z
    Calis, KA
    Choucair, WK
    CLINICAL CARDIOLOGY, 2000, 23 (11) : 803 - 807
  • [2] Endothelin in congestive heart failure
    Love, MP
    McMurray, JJV
    CARDIOLOGY, 1996, 91 : 21 - 29
  • [3] Endothelin in congestive heart failure
    Love, MP
    McMurray, JJV
    BASIC RESEARCH IN CARDIOLOGY, 1996, 91 : 21 - 29
  • [4] Renal endothelin system in a rabbit model of congestive heart failure
    Friedrich, EB
    Muders, F
    Luchner, A
    Eisner, D
    CIRCULATION, 1998, 98 (17) : 212 - 212
  • [5] Endothelin receptor blockade in congestive heart failure
    Cheng, TO
    CIRCULATION, 2001, 104 (18) : E96 - E96
  • [6] ENDOTHELIN IN HUMAN CONGESTIVE-HEART-FAILURE
    WEI, CM
    LERMAN, A
    RODEHEFFER, RJ
    MCGREGOR, CGA
    BRANDT, RR
    WRIGHT, S
    KAO, PC
    EDWARDS, WD
    BURNETT, JC
    HEUBLEIN, DM
    CIRCULATION, 1994, 89 (04) : 1580 - 1586
  • [7] LUNG IN CONGESTIVE HEART FAILURE
    EBERT, RV
    ARCHIVES OF INTERNAL MEDICINE, 1961, 107 (03) : 450 - &
  • [8] Contribution of the endothelin system to the renal hypoperfusion associated with experimental congestive heart failure
    Friedrich, EB
    Muders, F
    Luchner, A
    Dietl, O
    Riegger, GAJ
    Elsner, D
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 34 (04) : 612 - 617
  • [9] A POTENTIAL ROLE FOR ENDOTHELIN IN CONGESTIVE-HEART-FAILURE
    ZIMMERMAN, RS
    MAYO CLINIC PROCEEDINGS, 1992, 67 (08) : 801 - 803
  • [10] ENDOTHELIN LEVELS IN SEVERE CONGESTIVE-HEART-FAILURE
    CACOUB, P
    DORENT, R
    CARAYON, A
    NATAF, P
    LEGER, P
    GODEAU, P
    CABROL, C
    GANDJBAKHCH, I
    CIRCULATION, 1992, 86 (04) : 51 - 51